Case Notification of Cutaneous Leishmaniasis at Different Elevations in the North-Central Ethiopia from 2018 To 2022
- PMID: 39318813
- PMCID: PMC11417984
- DOI: 10.18502/ijpa.v19i3.16395
Case Notification of Cutaneous Leishmaniasis at Different Elevations in the North-Central Ethiopia from 2018 To 2022
Abstract
Background: We aimed to analyze a four-year trend of Cutaneous leishmaniasis (CL) to determine risk levels and hotspots in North-central Ethiopia.
Methods: This retrospective study was conducted at Boru Meda Hospital (BMH) from March to April 2023, focusing on CL patients treated at the leishmaniasis treatment center (LTC). Data collected included age, gender, CL type, and other clinical factors. Each patient's origin was traced and geographically mapped by elevation to assess CL risk levels.
Results: There were a total of 573 CL patients reported from 46 districts, with a higher number of male patients (n=356) compared to female patients (n=217) (P <0.001). The median age of the patients was 21 years [15-30], with the highest number of CL cases observed among individuals aged 16 to 30 years. The majority of cases (69%) presented with localized CL (LCL). About 39% of patients had a previous treatment history for CL. A significant clustering of CL cases was observed at elevation of 2301-3300 meters above sea level (χ2:17.5; P <0.001), with the highest incidence (case notification) of 14.2/100,000 population.
Conclusion: Foci of CL, were burdened at higher elevations and no clinical variation were observed between elevation differences. The majority of cases were concentrated in an area covering approximately 21.4% of the total land mass. CL continues to be a significant issue in North-central Ethiopia and has the potential to spread to new areas.
Keywords: Case notification; Cutaneous leishmaniasis; Ethiopia; Leishmania aethiopica.
Copyright © 2024 Gashaw et al. Published by Tehran University of Medical Sciences.
Conflict of interest statement
Conflict of interest The authors declare that they have no competing interests
Similar articles
-
Clinical features and treatment response of cutaneous leishmaniasis in North-West Ethiopia.Trop Med Int Health. 2017 Oct;22(10):1293-1301. doi: 10.1111/tmi.12928. Epub 2017 Aug 13. Trop Med Int Health. 2017. PMID: 28712122
-
First report of cutaneous leishmaniasis caused by Leishmania donovani in Ethiopia.Parasit Vectors. 2023 Dec 16;16(1):457. doi: 10.1186/s13071-023-06057-9. Parasit Vectors. 2023. PMID: 38104111 Free PMC article.
-
Miltefosine for the treatment of cutaneous leishmaniasis-A pilot study from Ethiopia.PLoS Negl Trop Dis. 2021 May 28;15(5):e0009460. doi: 10.1371/journal.pntd.0009460. eCollection 2021 May. PLoS Negl Trop Dis. 2021. PMID: 34048461 Free PMC article.
-
Cutaneous Leishmaniasis Due to Leishmania aethiopica.EClinicalMedicine. 2019 Jan 8;6:69-81. doi: 10.1016/j.eclinm.2018.12.009. eCollection 2018 Dec. EClinicalMedicine. 2019. PMID: 31193672 Free PMC article. Review.
-
Zoonotic impact and epidemiological changes of leishmaniasis in Ethiopia.Open Vet J. 2018;8(4):432-440. doi: 10.4314/ovj.v8i4.13. Epub 2018 Nov 16. Open Vet J. 2018. PMID: 30538935 Free PMC article. Review.
Cited by
-
Clinical Profiles and Outcomes of rK39-Confirmed Paediatric Visceral Leishmaniasis at a General Hospital in Massawa, Eritrea: A Retrospective Study.Int J Gen Med. 2025 Jun 26;18:3451-3462. doi: 10.2147/IJGM.S512429. eCollection 2025. Int J Gen Med. 2025. PMID: 40589799 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous